Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesReceivablesReceivables - AccuredReceivables - NetRetained EarningsSecurities - Mortgage Backed SecuritiesSecurities - TradableShareholder's EquityShares OutstandingShort-term InvestmentsTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Global Indemnity (GBLI) Other Accumulated Expenses (2021 - 2025)

Global Indemnity has reported Other Accumulated Expenses over the past 5 years, most recently at $761.7 million for Q3 2025.

  • For Q3 2025, Other Accumulated Expenses fell 9.34% year-over-year to $761.7 million; the TTM value through Sep 2025 reached $761.7 million, down 9.34%, while the annual FY2024 figure was $800.4 million, 5.9% down from the prior year.
  • Other Accumulated Expenses for Q3 2025 was $761.7 million at Global Indemnity, down from $776.1 million in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $867.0 million in Q2 2023 and troughed at $759.9 million in Q4 2021.
  • A 5-year average of $823.1 million and a median of $840.2 million in 2024 define the central range for Other Accumulated Expenses.
  • Biggest five-year swings in Other Accumulated Expenses: rose 9.54% in 2022 and later decreased 9.34% in 2025.
  • Year by year, Other Accumulated Expenses stood at $759.9 million in 2021, then rose by 9.54% to $832.4 million in 2022, then increased by 2.19% to $850.6 million in 2023, then dropped by 5.9% to $800.4 million in 2024, then dropped by 4.84% to $761.7 million in 2025.
  • Business Quant data shows Other Accumulated Expenses for GBLI at $761.7 million in Q3 2025, $776.1 million in Q2 2025, and $794.8 million in Q1 2025.